Healthcare Professionals
Versa
Pacemaker
Versa Pacemaker
The Versa® Pacing System combines physiologic pacing with automaticity. It’s versatile and automatic.
Overview
Why Is it Critical to Pace Less?
Reducing unnecessary ventricular pacing has been shown to improve clinical outcomes by reducing the risks of atrial fibrillation (AF)1-4 and heart failure hospitalization (HFH)1,4
There is a 1% increase in the risk of AF for each 1% increase in cumulative right ventricular pacing.4
Important Safety Information
Changes in a patient's disease and/or medications may alter the efficacy of a device's programmed parameters or related features.
Risk of AF
RV pacing > 40% of the time in DDDR mode was associated with a 2.6-fold increased risk of HFH compared with pacing < 40%.4
How It Works
How the Versa Pacing System Works
The new standard of care in pacing is to reduce unnecessary right ventricular pacing to as close to zero as possible. Mounting evidence suggests that right ventricular pacing is associated with a variety of detrimental effects, including risk of heart failure hospitalization and atrial fibrillation.1 The Versa pacing system combines physiologic pacing with automaticity.
Search AV+ Promotes Intrinsic Conduction
- Search AV®+ (SAV+) automatically and continuously searches for natural intrinsic conduction.
- SAV+ reduces unnecessary right ventricular pacing to less than 20%*2
- RV pacing > 40% of the time in DDDR mode was associated with a 2.6-fold increased risk of HFH compared with pacing < 40%.1
Risk of Heart Failure Hospitalization (HFH) 1
Completely Automatic – Simple to Use
Atrial Capture Management and Ventricular Capture Management (ACM and VCM):
- Provide complete long-term threshold management automatically
- Ensure pacing outputs remain at safe levels3
- Adapt programmed outputs to actively manage battery current drain
TherapyGuide™ – Tailored, Clinically-Oriented Programming Using Physician-Selected Parameters
- Simplifies and tailors programming
- Provides suggested device settings based on physician-selected patient conditions
TherapyGuide simplifies programming
Quick Look™ II – All Key Information on One Screen
- Simplifies clinic follow-up with all key information on one screen
- Provides concise overview of patient, device, and lead status
- Routine follow-up measurements are performed automatically
- All measurements are automatic and displayed upon initial interrogation
Detail - Quick Look II on One Screen
Cardiac Compass® Trends
Concise information to:
- Identify atrial arrhythmias
- Make key therapy decisions (eg, titrating medications)
- Monitor results of therapy changes
Assess Rhythm Control*
* Atrial Arrhythmia Trend of patient who received a change in antiarrhythmic drug therapy during an August follow-up. The change in medical therapy resulted in the decreased incidence and duration of AT/AF.
Assess Rate Control†
Rate Histogram of ventricular beats during exercise-induced AT/AF showing blocked conduction.
Rate Histogram of ventricular beats showing good conduction and rate control following change to patient's pharmacologic therapies for AT/AF.
† The information collected may help with assessment of rate control and risk for stroke in patients with atrial tachyarrhythmias.
Therapeutic Options for AT/AF
Pacing therapies that may help manage tachyarrhythmias and may alleviate symptoms:
- Atrial Preference Pacing (APP)
- Post Mode Switch Overdrive Pacing (PMOP)
- Conducted AF Response
Therapeutic options for atrial tachycardia and atrial fibrillation
Medtronic CareLink Network for Pacemakers
Medtronic CareLink® Network, the leading Internet-based remote monitoring service, is now available for pacemakers.
* Median number
References
1
Sweeney M, Hellkamp A, Ellenbogen K, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107:2932-2937.
2
Melzer C, Sowelam S, Sheldon TJ, et al. Reduction of right ventricular pacing in patients with sinus node dysfunction using an enhanced search AV algorithm. Pacing Clin Electrophysiol. June 2005; 28(6):521-527.
3
Sperzel J, Milasinovic G, Smith TW, et al. Automatic measurement of atrial pacing thresholds in dual-chamber pacemakers: Clinical experience with atrial capture management. Heart Rhythm. 2005;2(11):1203-1210.
References
1
Anderson HR, Nielsen JC, Thomsen PEB, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997;350:1210-1216.
2
Skanes AC, Krahn AD, Yee R, et al, for the CTOPP Investigators. Progression to chronic atrial fibrillation after pacing: The Canadian Trial Of Physiologic Pacing. J Am Coll Cardiol. 2001;38:167-172.
3
Neilsen J, Kristensen L, Andersen H, et al. A randomized comparison of atrial and dual chamber pacing in 177 consecutive patients with sick sinus syndrome. J Am Col Cardiol. 2003;42:614-623.
4
Sweeney M, Hellkamp A, Ellenbogen K, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation. 2003;107:2932-2937.